Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Asset Writedowns and Impairment (2016 - 2018)

Ironwood Pharmaceuticals (IRWD) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with $151.8 million as the latest value for Q3 2018.

  • Quarterly Asset Writedowns and Impairment changed N/A to $151.8 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $153.6 million through Sep 2019, changed 0.0% year-over-year, with the annual reading at $151.8 million for FY2018, N/A changed from the prior year.
  • Asset Writedowns and Impairment hit $151.8 million in Q3 2018 for Ironwood Pharmaceuticals, up from $1.8 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $151.8 million in Q3 2018 to a low of $1.8 million in Q2 2018.
  • Historically, Asset Writedowns and Impairment has averaged $31.5 million across 4 years, with a median of $9.5 million in 2014.
  • Biggest YoY gain for Asset Writedowns and Impairment was 43.82% in 2015; the steepest drop was 43.82% in 2015.
  • Year by year, Asset Writedowns and Impairment stood at $11.4 million in 2014, then crashed by 56.14% to $5.0 million in 2015, then soared by 102.0% to $10.1 million in 2016, then surged by 1402.97% to $151.8 million in 2018.
  • Business Quant data shows Asset Writedowns and Impairment for IRWD at $151.8 million in Q3 2018, $1.8 million in Q2 2018, and $10.1 million in Q4 2016.